Table 2.

Univariate analysis for EOR, adjuvant therapy, and WHO classification

	Overall survival		Progression-free survival
	Median	95% CI	Median	95% CI
LD (cm)		0.553		0.164
< 5.0	91.52	(65.30, 117.73)	61.31	(40.24, 82.37)
≥ 5.0	70.23	(53.28, 87.18)	42.04	(27.29,56.80)
EORa		0.270		0.024
GTR	92.68	(72.65, 112.72)	60.66	(44.89, 76.44)
STR	88.57	(65.59, 111.55)	36.73	(22.60, 50.85)
Adjuvant therapy		0.057		0.06
With AT	99.98	(83.45, 116.53)	51.46	(39.09, 63.84)
Without AT	30.38	(21.14, 39.61)	22.14	(10.33, 33.95)
WHO gradea		0.254		0.017
Grade I	92.54	(54.61, 130.48)	86.00	(74.12, 97.88)
Grade II	–	–	26.09	(18.04, 34.14)
Grade III	81.81	(69.58, 103.04)	40.46	(28.46, 52.46)

^aEOR and WTO grade were statistically significant in PFS